AYUSH-64 manufactured by Shree Dhootapapeshwar Ltd. is an Ayurvedic formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush, Government of India. It has been scientifically tested and found to be useful in the treatment and management of asymptomatic, mild to moderate viral infections as a potential adjunct to standard care. AYUSH-64 helps to improve clinical recovery and quality of life.
Malaria, management of asymptomatic and mild to moderate COVID -19 patients
Each 500 mg of tablets contains Saptaparna (Alstonia schlorais) stem bark aq. extract 100 mg, Katuki (Picorhizza kurroa) rhizome/root aq. extract 100 mg, Chirayata (Swertia chirata) whole plant aq. extract 100 mg, Kuberaksha (Caesalpinia crista) seed choorna 200 mg
Dose: (For Adults)
For Malaria: 4 tablets of 500 mg thrice a day, after meals for 5-7 days or as directed by the Physician
For asymptomatic COVID -19 patients: 2 tablets of 500 mg twice a day, one hour after meals with warm water for 20 days or as directed by the Physician
For mild to moderate COVID -19 patients: 2 tablets of 500 mg thrice a day, one hour after meals with warm water for 20 days or as directed by the Physician
Net Quantity: 40 Tablets, 1000 Tablets